QIAGEN Lake Constance GmbH of Stockach at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers OEM

QIAGEN Lake Constance GmbH

Jacques-Schiesser-Str. 3, 78333 Stockach
Germany
Telephone +49 7771 9166-0
Fax +49 7771 9166-18
info-qlc@qiagen.com

Hall map

MEDICA 2018 hall map (Hall 3): stand E84

Fairground map

MEDICA 2018 fairground map: Hall 3

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.13  Other diagnostic equipment
  • 02  Laboratory Techology
  • 02.01  Analyser systems / equipment

Our products

Product category: Other diagnostic equipment, Analyser systems / equipment

aLF Reader: improve your usability to the max

The aLF Reader is a reliable, highly sensitive and accurate lateral flow reader with an intuitive workflow. The 7” touch screen display supported by an internal 1D/2D barcode scanner allows easy data entry. No special training is required to operate the reader.

Test cassettes for a variety of different assays can be placed into the device using the universal test cassette holder. This ensures exact and precise measurements with minimum variances are always achieved.

The aLF reader is an CE-IVD product, which supports all listed IVD assays for the aLF system.

Your test results can be printed out on a Dymo 450 label writer. The database of the aLF device is able to store up to 1000 test results with full database administration if you prefer not to print. A connection port via Ethernet to a middleware will ensure result transfer to your local network server and therefore allows easy administration of your results from your desktop.

More Less

About us

Company details

Our journey began in the mid-1980s, the early days of biotechnology. As an entrepreneurial spin-off of university research, QIAGEN created a simpler, safer way for laboratories to handle the painstaking tasks of preparing samples to explore the mysteries of DNA. Since then, we have expanded across the continuum of molecular testing to establish QIAGEN as a global leader in rapidly growing fields of molecular diagnostics and life sciences.

Today some 4,700 QIAGEN employees, based in more than 25 countries, provide expertise and service to customers nearly everywhere. Our people share a collaborative, truly global culture – plus a commitment to making improvements in life possible.

As a public company listed on the New York Stock and Frankfurt Prime Standard exchanges, QIAGEN embraces transparency, accountability and good corporate governance.

More Less